Zura Bio Statistics

Total Valuation

Zura Bio has a market cap or net worth of $83.58 million. The enterprise value is -$107.26 million.

Market Cap	83.58M
Enterprise Value	-107.26M

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025, after market close.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Zura Bio has 65.29 million shares outstanding. The number of shares has increased by 199.50% in one year.

Current Share Class	65.29M
Shares Outstanding	65.29M
Shares Change (YoY)	+199.50%
Shares Change (QoQ)	+16.53%
Owned by Insiders (%)	6.50%
Owned by Institutions (%)	49.23%
Float	37.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.53
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.36

Current Ratio	10.36
Quick Ratio	10.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.85% and return on invested capital (ROIC) is -24.51%.

Return on Equity (ROE)	-36.85%
Return on Assets (ROA)	-21.40%
Return on Invested Capital (ROIC)	-24.51%
Return on Capital Employed (ROCE)	-29.44%
Revenue Per Employee	n/a
Profits Per Employee	-$2.84M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.32% in the last 52 weeks. The beta is 0.06, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	-63.32%
50-Day Moving Average	1.79
200-Day Moving Average	3.33
Relative Strength Index (RSI)	39.09
Average Volume (20 Days)	266,178

Short Selling Information

The latest short interest is 5.13 million, so 7.85% of the outstanding shares have been sold short.

Short Interest	5.13M
Short Previous Month	4.88M
Short % of Shares Out	7.85%
Short % of Float	13.75%
Short Ratio (days to cover)	5.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-50.28M
Pretax Income	-58.52M
Net Income	-42.62M
EBITDA	n/a
EBIT	-50.28M
Earnings Per Share (EPS)	-$0.66

Full Income Statement

Balance Sheet

The company has $188.22 million in cash and n/a in debt, giving a net cash position of $188.22 million or $2.88 per share.

Cash & Cash Equivalents	188.22M
Total Debt	n/a
Net Cash	188.22M
Net Cash Per Share	$2.88
Equity (Book Value)	170.83M
Book Value Per Share	2.34
Working Capital	170.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.31 million and capital expenditures -$30,000, giving a free cash flow of -$21.34 million.

Operating Cash Flow	-21.31M
Capital Expenditures	-30,000
Free Cash Flow	-21.34M
FCF Per Share	-$0.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-199.50%
Shareholder Yield	-199.50%
Earnings Yield	-52.64%
FCF Yield	-26.35%

Analyst Forecast

The average price target for Zura Bio is $15.80, which is 1,134.38% higher than the current price. The consensus rating is "Buy".

Price Target	$15.80
Price Target Difference	1,134.38%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2